| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Jul―25 |
Diagnostic value of BinaxNOW antigen card for Severe Acute Respiratory Syndrome Coronavirus 2 |
Yue-Xue Mai, Jia-Hao Zhang, Xi-Feng Qian, Ke-Fan Wu, Xin Yin, Zhan-Fu Mo, et al. (+4) Xiao-Ying Zhong, Qi-Qing Ye, Zi-Yuan Yu, Xu-Guang Guo |
| 2 |
[GO] |
2022―May―21 |
Healthy humans can be a source of antibodies countering COVID-19 |
Nileena Velappan, Hau B. Nguyen, Sofiya Micheva-Viteva, Daniel Bedinger, Chunyan Ye, Betty Mangadu, et al. (+6) Austin J. Watts, Robert Meagher, Steven Bradfute, Bin Hu, Geoffrey S. Waldo, Antonietta M. Lillo |
| 3 |
[GO] |
2022―Jan―27 |
COVID-19 in Southeast Asia: current status and perspectives |
Dinh-Toi Chu, Suong-Mai Vu Ngoc, Hue Vu Thi, Yen-Vy Nguyen Thi, Thuy-Tien Ho, Van-Thuan Hoang, et al. (+2) Vijai Singh, Jaffar A. Al-Tawfiq |
| 4 |
[GO] |
2022―Jan―20 |
Apigenin analogues as SARS-CoV-2 main protease inhibitors: In-silico screening approach |
Ameny Farhat, Hajer Ben Hlima, Bassem Khemakhem, Youssef Ben Halima, Philippe Michaud, Slim Abdelkafi, Imen Fendri |
| 5 |
[GO] |
2022―Jan―17 |
Inflammatory activation and immune cell infiltration are main biological characteristics of SARS-CoV-2 infected myocardium |
Rui Zhang, Xi Chen, Wenjie Zuo, Zhenjun Ji, Yangyang Qu, Yamin Su, et al. (+4) Mingming Yang, Pengfei Zuo, Genshan Ma, Yongjun Li |
| 6 |
[GO] |
2021―Dec―30 |
Paper-based microfluidic chip for rapid detection of SARS-CoV-2 N protein |
Mingdi Sun, Man Han, Shengnan Xu, Kai Yan, Gul Nigal, Tongyang Zhang, Bo Song |
| 7 |
[GO] |
2021―Dec―21 |
Bioinformatics and in-silico findings reveal medical features and pharmacological targets of biochanin A against colorectal cancer and COVID-19 |
Jingru Qin, Chao Guo, Lu Yang, Xiao Liang, Aijun Jiao, Keng Po Lai, Bin Yang |
| 8 |
[GO] |
2021―Oct―28 |
Sophorolipid: A glycolipid biosurfactant as a potential therapeutic agent against COVID-19 |
Amita Daverey, Kasturi Dutta, Sanket Joshi, Achlesh Daverey |
| 9 |
[GO] |
2021―Oct―07 |
Recent findings and applications of biomedical engineering for COVID-19 diagnosis: A critical review |
Le Minh Bui, Huong Thi Thu Phung, Thuy-Tien Ho Thi, Vijai Singh, Rupesh Maurya, Khushal Khambhati, et al. (+4) Chia-Ching Wu, Md Jamal Uddin, Do Minh Trung, Dinh Toi Chu |
| 10 |
[GO] |
2021―Aug―26 |
An easy method for developing fusion enabled SARS-CoV2 virus fusion mimic (SCFM), bypassing the need of Bio Safety Level (BSL) facility |
Abhishek Das, Satarupa Dutta, Dewanshu Sharma, Amit Pal, Nirmalya Ganguli, Subeer S. Majumdar |
| 11 |
[GO] |
2021―Jul―06 |
Characteristics of Angiotensin I-converting enzyme 2, type II transmembrane serine protease 2 and 4 in tree shrew indicate it as a potential animal model for SARS-CoV-2 infection |
Na Li, Wenpeng Gu, Caixia Lu, Xiaomei Sun, Pinfen Tong, Yuanyuan Han, et al. (+2) Wenguang Wang, Jiejie Dai |
| 12 |
[GO] |
2021―Jun―03 |
Identifying the molecular targets and mechanisms of xuebijing injection for the treatment of COVID-19 via network parmacology and molecular docking |
Zhao Tianyu, Guan Liying |
| 13 |
[GO] |
2021―Apr―17 |
Can algae contribute to the war with Covid-19? |
Wen Yi Chia, Hanz Kok, Kit Wayne Chew, Sze Shin Low, Pau Loke Show |
|
